Context Therapeutics Inc. (NASDAQ:CNTX) IPO

Context Therapeutics Inc.

IPO

Priced at US$5.00 a share on Oct 19, 2021.

Price
US$5.00 a share
Shares offered
5,000,000 shares of common stock
Offering size
US$25 million
Underwriters' option
Up to 750,000 more shares
Underwriter
ThinkEquity
Shares delivered
On or about Oct 22, 2021

Steps

StepWhen
Draft sent to the SEC in confidenceMar 22, 2021
Filed publiclyMay 27, 2021
Amended 7 timesNewest Oct 18, 2021
Shares registered with an exchangeJul 23, 2021
Declared effective by the SECOct 19, 2021
Final prospectus, with the priceOct 20, 2021

Filings

FilingFiled
424B4 · ProspectusOct 20, 2021
EFFECT · Notice that a registration is effectiveOct 19, 2021
FWP · Free writing prospectusOct 18, 2021
S-1/A · Registration statement, amendedOct 18, 2021
CORRESP · Letter to the SECOct 15, 2021
CORRESP · Letter to the SECOct 15, 2021
FWP · Free writing prospectusSep 29, 2021
S-1/A · Registration statement, amendedSep 29, 2021
CORRESP · Letter to the SECSep 24, 2021
FWP · Free writing prospectusSep 24, 2021
S-1/A · Registration statement, amendedSep 24, 2021
UPLOAD · Letter from the SECSep 22, 2021
FWP · Free writing prospectusSep 13, 2021
S-1/A · Registration statement, amendedSep 13, 2021
CORRESP · Letter to the SECAug 2, 2021
CORRESP · Letter to the SECAug 2, 2021
CERT · Exchange's certificate of listingJul 27, 2021
8-A12B · Registration of shares for listing on an exchangeJul 23, 2021
CORRESP · Letter to the SECJul 23, 2021
S-1/A · Registration statement, amendedJul 23, 2021
CORRESP · Letter to the SECJul 23, 2021
CORRESP · Letter to the SECJul 23, 2021
UPLOAD · Letter from the SECJul 12, 2021
FWP · Free writing prospectusJul 12, 2021
FWP · Free writing prospectusJul 12, 2021
FWP · Free writing prospectusJul 2, 2021
S-1/A · Registration statement, amendedJul 2, 2021
CORRESP · Letter to the SECJul 1, 2021
CORRESP · Letter to the SECJul 1, 2021
S-1/A · Registration statement, amendedJun 16, 2021
UPLOAD · Letter from the SECJun 4, 2021
CORRESP · Letter to the SECMay 27, 2021
S-1 · Registration statementMay 27, 2021
UPLOAD · Letter from the SECMay 20, 2021
DRS/A · Draft registration statement, amendedMay 3, 2021
DRSLTR · Letter to the SEC with a draftApr 30, 2021
UPLOAD · Letter from the SECApr 22, 2021
DRS · Draft registration statementMar 22, 2021

From the cover of the final prospectus (424B4) filed Oct 20, 2021